Medication nonadherence and psychiatry

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Nonadherence to appropriately prescribed medication for psychiatric disorders prevents patients from realizing the full benefits of their treatment and negatively impacts on individuals, their families and the healthcare system. Understanding and reducing nonadherence is therefore a key challenge to quality care for patients with psychiatric disorders. This review highlights findings regarding the prevalence and consequence of nonadherence, barriers to adherence and new intervention methods from 2012 onwards.

RECENT FINDINGS: Recent research has highlighted that nonadherence is a global challenge for psychiatry and has linked nonadherence to poorer outcomes, including hospital admissions, suicide and mortality. Optimizing medication regimens can reduce nonadherence; however, often a complex interplay of factors affects individuals' motivation and ability to follow their prescription. Psychiatrists can enable patients to develop an accurate model of their illness and treatment and facilitate adherence. However, nonadherence is often a hidden issue within consultations. Novel interventions using new technologies and tailoring techniques may have the potential to reduce nonadherence.

SUMMARY: Nonadherence remains a significant challenge for patients with psychiatric disorders, physicians and healthcare systems. New developments demonstrate the importance of developing tailored interventions to enable patients to overcome perceptual and practical barriers to adherence.

Original languageEnglish
Pages (from-to)446-452
Number of pages7
JournalCurrent Opinion in Psychiatry
Volume26
Issue number5
DOIs
Publication statusPublished - Sep 2013

Fingerprint

Medication Adherence
Psychiatry
Delivery of Health Care
Aptitude
Quality of Health Care
Suicide
Prescriptions
Motivation
Referral and Consultation
Technology
Physicians
Mortality
Therapeutics
Research

Keywords

  • Health Behavior
  • Humans
  • Medication Adherence
  • Mental Disorders
  • Journal Article
  • Review

Cite this

Medication nonadherence and psychiatry. / Chapman, Sarah C E; Horne, Rob.

In: Current Opinion in Psychiatry, Vol. 26, No. 5, 09.2013, p. 446-452.

Research output: Contribution to journalArticle

Chapman, Sarah C E ; Horne, Rob. / Medication nonadherence and psychiatry. In: Current Opinion in Psychiatry. 2013 ; Vol. 26, No. 5. pp. 446-452.
@article{f45c74b45077489fb45f75b2fd8506c1,
title = "Medication nonadherence and psychiatry",
abstract = "PURPOSE OF REVIEW: Nonadherence to appropriately prescribed medication for psychiatric disorders prevents patients from realizing the full benefits of their treatment and negatively impacts on individuals, their families and the healthcare system. Understanding and reducing nonadherence is therefore a key challenge to quality care for patients with psychiatric disorders. This review highlights findings regarding the prevalence and consequence of nonadherence, barriers to adherence and new intervention methods from 2012 onwards.RECENT FINDINGS: Recent research has highlighted that nonadherence is a global challenge for psychiatry and has linked nonadherence to poorer outcomes, including hospital admissions, suicide and mortality. Optimizing medication regimens can reduce nonadherence; however, often a complex interplay of factors affects individuals' motivation and ability to follow their prescription. Psychiatrists can enable patients to develop an accurate model of their illness and treatment and facilitate adherence. However, nonadherence is often a hidden issue within consultations. Novel interventions using new technologies and tailoring techniques may have the potential to reduce nonadherence.SUMMARY: Nonadherence remains a significant challenge for patients with psychiatric disorders, physicians and healthcare systems. New developments demonstrate the importance of developing tailored interventions to enable patients to overcome perceptual and practical barriers to adherence.",
keywords = "Health Behavior, Humans, Medication Adherence, Mental Disorders, Journal Article, Review",
author = "Chapman, {Sarah C E} and Rob Horne",
year = "2013",
month = "9",
doi = "10.1097/YCO.0b013e3283642da4",
language = "English",
volume = "26",
pages = "446--452",
journal = "Current Opinion in Psychiatry",
issn = "0951-7367",
publisher = "Lippincott Williams & Wilkins",
number = "5",

}

TY - JOUR

T1 - Medication nonadherence and psychiatry

AU - Chapman, Sarah C E

AU - Horne, Rob

PY - 2013/9

Y1 - 2013/9

N2 - PURPOSE OF REVIEW: Nonadherence to appropriately prescribed medication for psychiatric disorders prevents patients from realizing the full benefits of their treatment and negatively impacts on individuals, their families and the healthcare system. Understanding and reducing nonadherence is therefore a key challenge to quality care for patients with psychiatric disorders. This review highlights findings regarding the prevalence and consequence of nonadherence, barriers to adherence and new intervention methods from 2012 onwards.RECENT FINDINGS: Recent research has highlighted that nonadherence is a global challenge for psychiatry and has linked nonadherence to poorer outcomes, including hospital admissions, suicide and mortality. Optimizing medication regimens can reduce nonadherence; however, often a complex interplay of factors affects individuals' motivation and ability to follow their prescription. Psychiatrists can enable patients to develop an accurate model of their illness and treatment and facilitate adherence. However, nonadherence is often a hidden issue within consultations. Novel interventions using new technologies and tailoring techniques may have the potential to reduce nonadherence.SUMMARY: Nonadherence remains a significant challenge for patients with psychiatric disorders, physicians and healthcare systems. New developments demonstrate the importance of developing tailored interventions to enable patients to overcome perceptual and practical barriers to adherence.

AB - PURPOSE OF REVIEW: Nonadherence to appropriately prescribed medication for psychiatric disorders prevents patients from realizing the full benefits of their treatment and negatively impacts on individuals, their families and the healthcare system. Understanding and reducing nonadherence is therefore a key challenge to quality care for patients with psychiatric disorders. This review highlights findings regarding the prevalence and consequence of nonadherence, barriers to adherence and new intervention methods from 2012 onwards.RECENT FINDINGS: Recent research has highlighted that nonadherence is a global challenge for psychiatry and has linked nonadherence to poorer outcomes, including hospital admissions, suicide and mortality. Optimizing medication regimens can reduce nonadherence; however, often a complex interplay of factors affects individuals' motivation and ability to follow their prescription. Psychiatrists can enable patients to develop an accurate model of their illness and treatment and facilitate adherence. However, nonadherence is often a hidden issue within consultations. Novel interventions using new technologies and tailoring techniques may have the potential to reduce nonadherence.SUMMARY: Nonadherence remains a significant challenge for patients with psychiatric disorders, physicians and healthcare systems. New developments demonstrate the importance of developing tailored interventions to enable patients to overcome perceptual and practical barriers to adherence.

KW - Health Behavior

KW - Humans

KW - Medication Adherence

KW - Mental Disorders

KW - Journal Article

KW - Review

UR - https://doi.org/10.1097/YCO.0b013e3283642da4

U2 - 10.1097/YCO.0b013e3283642da4

DO - 10.1097/YCO.0b013e3283642da4

M3 - Article

VL - 26

SP - 446

EP - 452

JO - Current Opinion in Psychiatry

JF - Current Opinion in Psychiatry

SN - 0951-7367

IS - 5

ER -